ALW-II-41-27 modulates cellular processes such as angiogenesis, cell migration, and axon guidance, with potential applications in oncology and neurobiology.
Molecular Weight
607.69
Molecular Formula
C32H32F3N5O2S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
ALW-II-41-27 acts as an Ephrin receptor inhibitor, used in research studies exploring cancer cell invasion and metastasis.
About Us
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
